CIN: U24299DL2018PTC340995 GSTIN: 20AAICB0857H1Z0 corpcomm@baylespharma.com
New Delhi, India
New Delhi
Products / Otolaryngology

Snuvia-FX Tablet

Otolaryngology

Snuvia-FX Tablet

Active Composition: Montelukast Sodium 10 mg + Fexofenadine Hydrochloride 120 mg
Therapeutic Indications / Uses

Severe Allergic Rhinitis Sneezing Nasal Allergy Ocular Allergy

Pack Packaging Size: 10 x 10
Prescription Classification: Schedule H (Prescription Required)